CHO cells are like tiny factories. They make important medicines that help people fight diseases. But they are not very efficient. Scientists have been trying to make them better for years. They have tried many different methods. Some of these methods work well. But the results are not as good as ho
Yeasts are tiny powerhouses. They've been helping humans make bread, beer, and wine for ages. Now, scientists are using them to make medicines too. One such yeast, Kluyveromyces lactis, is known for its work in the dairy industry. But now, it's being used in a new way. Scientists have developed a me
The 15th European Immunogenicity Platform Open Symposium took place in Lisbon from February 22-24, 2024. This event brought together professionals from various fields, including industry, regulatory bodies, and academia. They gathered to discuss the challenges posed by the immune response to bioph
Creating stable formulations for biopharmaceuticals like infliximab is no easy task. Scientists explored using 2-hydroxypropyl-β-cyclodextrin (HP-β-CD) to keep infliximab from degrading. They made both liquid and solid formulations. For the solid version, they used a scaled-up high-speed electrospin
Biopharmaceuticals are on the rise, but they have a big problem—they tend to clump together quickly. Right now, we use surfactants like polysorbates and poloxamers to stop this from happening and make them last longer. However, these surfactants aren't very stable themselves. They change into many d
